Twitter becoming X has been big news, the global online chatroom has been stirring the pot since Elon Musk acquired the company for $44 billion. In February of this year, Twitter (now X) updated its advertising policy to allow cannabis ads on the platform in states where cannabis is legal. A huge win for market and makes them a rarity. It seems social media and marijuana, ugh when it comes to growing the industry.
With 90% of the public ok with some form of legal cannabis, you would think social media would be more accepting. But actually, marijuana falls into a similar category as alcohol with some of the largest players.
Photo by OsmanZekiDemirkale/Getty Images
Here is a quick review of the policies.
Meta (Facebook and Instagram)
Meta prohibits the advertising of cannabis, topical CBD, ingestible hemp products, and CBD products such as hemp seeds and ingestible CBD. However, Meta now allows limited CBD and hemp advertising on apps like Facebook and Instagram for educational, advocacy, and public service announcement purposes.
Meta allows alcohol advertising under certain restrictions and with strict guidelines.
TikTok
TikTok prohibits paid advertising for cannabis.
TikTok prohibits ads promoting alcoholic beverages such as wine, beer, spirits, etc. They also prohibit ads for alcohol clubs/subscription services, alcohol making kits, and alcohol-sponsored events
YouTube’s policies prohibit content that endangers the emotional and physical well-being of minors, including promoting products that contain drugs, nicotine, or controlled substances. YouTube’s policies also consider the nature of the upload, such as whether it is educational, documentary, scientific, or artistic in nature.
As of June 2021, YouTube no longer accepts Masthead Ads from certain verticals, including alcohol.
Photo by Vanessa Nunes/Getty Images
A study demonstrates the ways in which cannabis is promoted on social media apps, and how this has opened up the market to include people who don’t fit the typical stoner stereotype.
The study, published in Crime, Media, Culture: An International Journal, found that women have slowly introduced themselves into the equation, disrupting what’s traditionally thought of as a cannabis consumer. These women promote cannabis in different ways, incorporating it into their daily lives and activities.
Researchers used Instagram as their social media platform of choice, analyzing illegal sellers in Switzerland with “cannabis influencers” in the U.S., and spotting their differences. Researchers found that cannabis influencers were challenging what has long been considered appealing to cannabis markets, something that could have a global impact.
“Our findings show that cannabis influencers on Instagram are changing the stereotypical characteristics of illegal cannabis culture as being almost entirely dominated by men, to one where cannabis is represented as a desirable accessory in certain feminine lifestyles,” write the study’s researchers. These influencers painted cannabis as an activity that can be pursued by mothers, people who are invested in their physical and mental health, and more.
Study authors recognize how cannabis influencers have had to get creative on platforms like Instagram considering how the app prevents its sale and censors its content. In their posts, influencers make it clear that they’re not selling cannabis and are simply endorsing it, tying it to appealing images and to a lifestyle that other people are interested in replicating.
“When cannabis is marketed by legal influencers rather than illegal dealers, we find a shift in the use of symbols related to amateurism versus professionalism, intimacy and lifestyle and argue that these changes are bound up with how the influencers do gender differently than sellers,” explain the researchers
Marijuana use has evolved over the years, becoming less of a taboo topic and something that can be discussed and consumed openly. In places where the drug is legal, it makes sense social media always promotion as something that’s just another activity to partake in.
Tariffs are the word of the day – but marijuana consumers need to be ready to see a change also.
From apples to automobiles, hundreds of industries are trying to figure out the new tariffs. What is clear is prices are going up on a random amount of things. But, why is a surprise, is cannabis consumers are being hit by the tariffs also. Although cannabis itself cannot be imported or exported due to federal restrictions, the industry heavily relies on international suppliers for key components like vaporizer hardware, packaging, and cultivation equipment.
For instance, products sourced from China now face cumulative tariffs as high as 45%, including a 10% increase imposed in February 2025. Similarly, imports from Canada and Mexico face 25% tariffs. These measures have particularly affected items like vape cartridges, batteries, and specialized packaging materials, which are difficult to source domestically at competitive prices. As a result, many cannabis companies are passing these increased costs down the supply chain to consumer
The financial burden of these tariffs is substantial. Analysts estimate that most cannabis businesses lack the margin flexibility to absorb a 10%-15% cost increase. This has led to higher retail prices for products like pre-rolls and vaporizers, potentially pushing consumers toward cheaper, unregulated black-market alternatives. Such a shift raises concerns about product safety and could undermine the legal market’s growth.
Additionally, the tariffs have caused stock prices of major cannabis companies like Tilray Brands and Canopy Growth to decline by 5%-10%, reflecting investor concerns over profitability.Smaller businesses, already constrained by high taxes and limited banking access, are particularly vulnerable to these economic pressures.
Efforts to mitigate tariff-related expenses include exploring alternative manufacturing locations in countries like Malaysia or India. However, transitioning production is complex and time-consuming due to logistical hurdles and regulatory compliance requirements. Domestic production is another option but often comes with higher costs and limited capacity.
Packaging regulations in many states exacerbate the situation by requiring child-resistant designs, further limiting affordable domestic alternatives. Some companies are exploring sustainable packaging solutions as a long-term strategy to reduce dependence on volatile international markets.
The ongoing trade tensions show no signs of easing under Trump’s administration, leaving cannabis businesses with little choice but to adapt quickly. Strategies such as diversifying suppliers, investing in automation, and innovating with local materials may help companies weather the storm. However, without significant policy shifts or financial support mechanisms, the industry faces a challenging road ahead.
There is a buzz about sore throats today. While they are most common in colder months, spring allergies bring the pain also. This is often due to postnasal drip, which is when mucus from the nose and sinuses drains down the back of the throat, causing irritation and a scratchy feeling. Overuse of the voice, like talking loudly or singing for long periods, can tire out and strain the muscles in your throat, causing them to feel sore. The good news is cannabis can help a sore throat.
For those seeking natural alternatives to manage cold symptoms, cannabis is emerging as a promising option for throat irritation. Increasing research at medical center specifically targeting sore throats shows early insights. The data suggests cannabinoids and terpenes could offer symptom relief through their unique properties.
Photo by Esther Kelleter / EyeEm/Getty Images
Cannabis contains compounds like THC and CBD, which studies indicate possess anti-inflammatory properties that may reduce throat swelling and irritation. Terpenes such as eucalyptol—found in some strains—are traditionally associated with decongestant effects, potentially easing respiratory discomfort. These components work synergistically to calm inflamed tissues, though their direct impact on sore throats requires further clinical validation.
Smoking cannabis while ill remains controversial due to potential throat irritation from heat and smoke. Instead, experts recommend gentler options:
Edibles/lozenges: THC or CBD-infused products bypass inhalation, delivering localized relief without aggravating the throat.
Cannabis tea: Warm beverages with cannabis extracts may soothe scratchy throats while providing hydration.
Beyond direct throat relief, cannabis may improve overall wellness during illness. THC’s appetite-stimulating properties can combat reduced hunger, while its relaxing effects might promote restorative sleep. CBD’s muscle-relaxing qualities could help alleviate the body aches often accompanying colds.
While preliminary findings are encouraging, users should consult healthcare providers before combining cannabis with conventional cold medications due to potential interactions. Starting with low-dose CBD products may offer benefits without psychoactive effects. As legalization expands, more targeted research is expected to clarify cannabis’s role in respiratory health.
Innovative cannabis formulations—from throat-calming lozenges to anti-inflammatory teas—are redefining how we approach minor ailments. For those navigating cold season, these plant-based solutions present a compelling fusion of traditional herbal wisdom and modern cannabinoid science
Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.
The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.
The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.
During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.
The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.
The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.
While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.